Trial to Test ECT for Severe Agitation in Alzheimer’s

Mclean Hospital

Medscape

Dr. Brent Forester will lead a five-year study to investigate the use of electroconvulsive therapy (ECT) to treat severe agitation and aggression in people with Alzheimer’s disease.

Read Full Article

Topics

McLean Main Navigation

In the Media: Trial to Test ECT for Severe Agitation in Alzheimer’s

Medscape

Experts Draw Attention to the Opioid Crisis and Open Access to Screening

Let’s ‘Gab’-apentin: Aligning Evidence With Current Use

How to Stop Questioning Your Self-Worth and Doubting Your Successes

Sensory-Focused Strategies to Manage Daily Anxiety

In the Media: Trial to Test ECT for Severe Agitation in Alzheimer’s

Medscape

You May Also Like

ECT Shouldn’t Be a Last-Resort Treatment

Do Sports Fans Have Better Self-Esteem?

Study Will Enhance Training for Nurses Working With Dementia Patients

Special Podcast – A Conversation With the Cycle 1 IMPACT Pilot Study Awardees

Resources

Latest Videos

Experts Draw Attention to the Opioid Crisis and Open Access to Screening

Let’s ‘Gab’-apentin: Aligning Evidence With Current Use

How to Stop Questioning Your Self-Worth and Doubting Your Successes

Sensory-Focused Strategies to Manage Daily Anxiety

Keep Up With McLean!